Cargando…

Targeting integrin α5β1 in urological tumors: opportunities and challenges

Urological tumors, such as prostate cancer, renal cell carcinoma, and bladder cancer, have shown a significant rise in prevalence in recent years and account for a significant proportion of malignant tumors. It has been established that metastasis to distant organs caused by urological tumors is the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xuming, Zhu, Hezhen, Luo, Cong, Xiao, Huan, Zou, Xiaofeng, Zou, Junrong, Zhang, Guoxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358839/ https://www.ncbi.nlm.nih.gov/pubmed/37483505 http://dx.doi.org/10.3389/fonc.2023.1165073

Ejemplares similares

Therapeutic potential of vasculogenic mimicry in urological tumors
por: Lin, Xinyu, et al.
Publicado: (2023)

Prevention and Treatment of Side Effects of Immunotherapy for Bladder Cancer
por: Lou, Kecheng, et al.
Publicado: (2022)

The Potential Role of Exosomal Proteins in Prostate Cancer
por: Feng, Shangzhi, et al.
Publicado: (2022)

Clinical potential of the Hippo-YAP pathway in bladder cancer
por: Cheng, Xin, et al.
Publicado: (2022)

Tumor-Promoting ATAD2 and Its Preclinical Challenges
por: Liu, Haicheng, et al.
Publicado: (2022)

Extracellular vesicles derived from macrophages: Current applications and prospects in tumors
por: Lou, Kecheng, et al.
Publicado: (2022)

Obesity-Related Cross-Talk between Prostate Cancer and Peripheral Fat: Potential Role of Exosomes
por: Feng, Shangzhi, et al.
Publicado: (2022)

Functions of circular RNAs in bladder, prostate and renal cell cancer
por: Yang, Longfei, et al.
Publicado: (2021)

A Review of Recent Research on the Role of MicroRNAs in Renal Cancer
por: Yang, Longfei, et al.
Publicado: (2021)

In vivo evaluation of integrin αvβ6-targeting peptide in NSCLC and brain metastasis
por: Fan, Di, et al.
Publicado: (2023)

Impact of SOX2 function and regulation on therapy resistance in bladder cancer
por: Chen, Guodong, et al.
Publicado: (2022)

Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells
por: Phanthaphol, Nattaporn, et al.
Publicado: (2021)

Opportunities and challenges of targeting c-Met in the treatment of digestive tumors
por: Zhang, Zhengchao, et al.
Publicado: (2022)

Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling
por: Liu, Huan, et al.
Publicado: (2021)

Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges
por: Su, Pengxiao, et al.
Publicado: (2023)

Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
por: Mercogliano, María Florencia, et al.
Publicado: (2020)

CD36 and Its Role in Regulating the Tumor Microenvironment
por: Liao, Xinzhi, et al.
Publicado: (2022)

Preclinical models and evaluation criteria of prostatitis
por: He, Hailan, et al.
Publicado: (2023)

Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges
por: Wang, Juan, et al.
Publicado: (2022)

Tumor Targeting via Integrin Ligands
por: Marelli, Udaya Kiran, et al.
Publicado: (2013)

The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis
por: Roblek, Marko, et al.
Publicado: (2022)

Integrin α6β4 signals through DNA damage response pathway to sensitize breast cancer cells to cisplatin
por: Chen, Min, et al.
Publicado: (2022)

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
por: Gaipl, Udo S., et al.
Publicado: (2020)

Urinary Exosomes Diagnosis of Urological Tumors: A Systematic Review and Meta-Analysis
por: Xu, Yipeng, et al.
Publicado: (2021)

Evaluation of a CD13 and Integrin α(v)β(3) Dual-Receptor Targeted Tracer (68)Ga-NGR-RGD for Ovarian Tumor Imaging: Comparison With (18)F-FDG
por: Long, Yu, et al.
Publicado: (2022)

Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosis
por: Zou, Wei, et al.
Publicado: (2015)

Natural orifice transluminal endoscopic surgery in urology: The Chinese experience
por: Zou, Xiaofeng, et al.
Publicado: (2020)

Opportunities and Challenges for Successful Use of Bevacizumab in Pediatrics
por: Barone, Amy, et al.
Publicado: (2013)

Opportunities and Challenges of the Human Microbiome in Ovarian Cancer
por: Cheng, Huiyan, et al.
Publicado: (2020)

Challenges and Opportunities Associated With Platelets in Pancreatic Cancer
por: Chen, Zhou, et al.
Publicado: (2022)

Opportunities and Challenges for Gut Microbiota in Acute Leukemia
por: Ma, Tao, et al.
Publicado: (2021)

Ferroptosis in Glioma Immune Microenvironment: Opportunity and Challenge
por: Wang, Kaikai, et al.
Publicado: (2022)

Opportunities and challenges related to ferroptosis in glioma and neuroblastoma
por: Chi, Huizhong, et al.
Publicado: (2023)

UPS: Opportunities and challenges for gastric cancer treatment
por: Yang, Hang, et al.
Publicado: (2023)

Editorial: Cross-talk and interaction between endocrinology and urology: challenges and opportunities
por: Song, Yuxuan, et al.
Publicado: (2023)

Turning “Cold” Into “Hot” Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers
por: Sevenich, Lisa
Publicado: (2019)

Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and Challenges
por: Qiu, Bo, et al.
Publicado: (2021)

Laminin-bound integrin α6β4 promotes non-small cell lung cancer progression via the activation of YAP/TAZ signaling pathway
por: Zhao, Xiaopeng, et al.
Publicado: (2022)

Big Data in Designing Clinical Trials: Opportunities and Challenges
por: Mayo, Charles S., et al.
Publicado: (2017)

Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade
por: Yang, Jianjun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_on2qdephahkeeivqc7cvb86mal